Cardiac Involvement in COVID-19

<p>Cardiac Involvement in COVID-19</p> <p>Guest: Patricia A. Pellikka, M.D. (<a href='https://twitter.com/pattypellikka'>@pattypellikka</a>)</p> <p>Host: Paul A. Friedman, M.D. (<a href='https://twitter.com/drpaulfriedman'>@drpaulfriedman</a>)</p> <p>Early reports from Wuhan, China, noted that patients with underlying cardiovascular disease had a higher risk of morbidity and mortality if they contracted the COVID-19 virus. More recently, data support that patients with evidence of cardiac disease during their COVID-19 episodes also have higher rates of morbidity and mortality during hospitalization for treatment of COVID-19.</p> <p>Joining us today to discuss the cardiac involvement in patients with COVID-19 is Patricia A. Pellikka, M.D., vice chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota.</p> <p>Specific topics discussed:</p> <ul><li>Significance of cardiac involvement in patients with COVID-19</li> <li>Diagnosis of cardiac dysfunction in patients with COVID-19</li> <li>Myocarditis and other cardiac injury in patients with COVID-19</li> <li>Implications of MRI-identified myocarditis</li> <li>COVID-19 long-haulers and cardiac evaluation</li> <li>Artificial intelligence in electrocardiogram or echocardiogram</li> </ul> <p>Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at <a href='https://cveducation.mayo.edu'>https://cveducation.mayo.edu</a> or on Twitter <a href='https://www.twitter.com/mayocliniccv'>@MayoClinicCV</a>.</p> <p>No CME credit offered for this episode.</p> <p>Podcast episode transcript <a href='https://mcdn.podbean.com/mf/web/kvgy9t/P-MayoCV11_Cardiac_Involvement_in_COVID-19_Friedman-Pellikka_CC_Transcript_Finalaxpa9.pdf'>here</a>.</p>